GOTTUMUKKALA, Narendra Varma, Aneta LEDEREROVÁ, Lenka DOSTÁLOVÁ, Adriana LADUNGOVÁ, Yusuf LODHI a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity py preventing CD19 antigen escape in relapsed models. In EHA Meeting – 5th European CAR T-cell Meeting, Rotterdam, Nizozemsko. 2023.
LODHI, Yusuf, Adriana LADUNGOVÁ, Daniel BUŠA, Helena PESCHELOVÁ, Martin ČULEN a Michal ŠMÍDA. Genome-wide Screening Optimizations and High-throughput Compound Screening to Identify Novel Treatment Options in Venetoclax-resistant AML. In Annual PhD conference Biomedical sciences, Brno. 2022.
GOTTUMUKKALA, Narendra Varma, Veronika MANČÍKOVÁ, Aneta LEDEREROVÁ, Veronika KOZLOVÁ, Lenka DOSTÁLOVÁ, Adriana LADUNGOVÁ, Yusuf LODHI, Jan VERNER a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models. In XVII. Myeloma and Cell Therapy Workshop, Ostrava. 2022.
GOTTUMUKKALA, Narendra Varma, Veronika MANČÍKOVÁ, Aneta LEDEREROVÁ, Veronika KOZLOVÁ, Lenka DOSTÁLOVÁ, Adriana LADUNGOVÁ, Yusuf LODHI, Jan VERNER a Michal ŠMÍDA. Chasing the epigenetic landscape to enhance CAR-T cell activity by preventing CD19 antigen escape in relapsed models. In Annual PhD conference Biomedical sciences, Brno. 2022.
LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN a Michal ŠMÍDA. Identification of novel therapeutic options for venetoclax-resistant AML cells through drug repurposing. In EHA 2022 in HemaSphere 2022; 6(S3): 626-627. 2022.
LADUNGOVÁ, Adriana, Daniel BUŠA, Yusuf LODHI, Jan HÝL, Martin ČULEN a Michal ŠMÍDA. Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing. In Functional Precision Medicine for Blood Cancer Workshop and Symposium, Helsinki, Finland. 2022.